We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





AI Chest CT Analysis Distinguishes COVID-19 from Pneumonia

By HospiMedica International staff writers
Posted on 31 Mar 2020
An artificial intelligence (AI) deep learning model can accurately detect COVID-19 and differentiate it from community acquired pneumonia (CAP) and other lung diseases, according to a new study.

Researchers at Wuhan Huangpi People's Hospital (China), Shenzhen University Health Science Center (Shenzhen, China), and other institutions conducted a multicenter, retrospective study to develop the COVID-19 detection neural network (COVNet), a fully automatic AI framework that extracts visual features from volumetric chest CT exams for the detection of COVID-19, and differentiates them from CAP and other lung findings. More...
Datasets were collected from six hospitals and diagnostic performance was assessed and evaluated.

In all, the collected dataset consisted of 4,356 volumetric chest CT exams from 3,322 patients (average age 49 years, 55% male). Overall per-exam sensitivity and specificity for detecting COVID-19 in the independent test set was 90% and 96%, respectively. The researchers also showed that the per-exam sensitivity and specificity for detecting CAP was 87% and 92%, respectively. The study was published on March 19, 2020, in Radiology.

“We were able to collect a large number of CT exams from multiple hospitals, which included 1,296 COVID-19 CT exams,” concluded lead author Lin Li, MD, of the Wuhan Huangpi People's Hospital department of radiology. “More importantly, 1,735 CAP and 1,325 non-pneumonia CT exams were also collected as the control groups in this study in order to ensure the detection robustness, considering that certain similar imaging features may be observed in COVID-19 and other types of lung diseases.”

The coronavirus Disease 2019 (COVID-19) outbreak has rapidly spread all over the world. On January 30, 2020, it was declared as a public health emergency of international concern by the World Health Organization (WHO). It is typically confirmed by reverse-transcription polymerase chain reaction (PCR), but CT can detect certain characteristic manifestations in the lung associated with COVID-19, such as bilateral ground-glass, consolidative pulmonary opacities on CT, and a crazy-paving pattern, among others.

Related Links:
Shenzhen University Health Science Center


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.